|
What
is the approval process
for GMOs in the European
Union?
Every GMO
released in the
environment for research
or marketing purposes
needs a special
authorization. Some
major principles of the
EU legal framework are
the following :
-
The risk assessment
is done on a
case-by-case,
step-by-step, and
use-by-use
basis. This means
that attention is
paid to the
peculiarities of
each individual GM
product, depending
on the interaction
between its novel
trait and a given
environment, and
considering its
intended uses (food,
feed, cultivation,
processing etc.).
The step-by-step
approach means that
GMOs are marketed
only after they have
been carefully
evaluated in a
contained
environment,
followed by
experimental field
releases.
-
Post-release
monitoring,
traceability and
labelling
:
as a general
provision of the
precautionary
principle,
monitoring plans
need to be approved
before issuing the
marketing consent
and the traceability
of the product on
the market is
ensured by labelling
and administrative
records throughout
the food chain.
Marketing approvals
are first granted
for a maximum of 10
years.
-
Public information
:
in the course of the
approval process,
information is
provided to the
public, via
abstracts of the
technical dossiers
submitted by the
applicants, via
opinion papers
published by the
EFSA and via the web
sites of national
authorities and of
the European
Commission in-house
research Center (JRC
of Ispra).
-
Subsidiarity
: although the aim
is the promote the
European market via
common rules, member
states may be
requested to develop
national answers to
questions raised by
GMOs. This is true
for the «
co-existence issue
», which refers to
the need to provide
the farmers with a
practical choice
between
conventional,
organic and GM crop
production, with
minimal adverse
economical effect.
Considering the
diversity of crop
and land management
practices across
Europe, legislators
estimated that the
member states were
in a better position
to identify the
effective and
justified measures
for achieving this
co-existence
objective, and the
Commission only
provided guidelines
via a Recommandation
on that issue
(2003/556/EC).
-
Compliance with the
international trade
rules
:
The EU regulation is
in line with the
international trade
requirements of WTO
(it is clear,
transparent and non
discriminatory) and
with the
transboundary
movement rules of
the UN Cartagena
Protocol on
Biosafety.
back
|
|
|
 |
|
|
Briefs
and Policy Reports |